Viewing nowLaraCap 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Youyoung Pharmaceutical Co., Ltd.

MFDS item code 201109030 · Approved 2011.10.24 · Insurance code 648203510
Relief of peripheral and central neuropathic pain, adjunctive treatment of partial epilepsy, improvement of fibromyalgia.
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also administered as an adjunct for patients with partial seizures in epilepsy to help alleviate their symptoms. Additionally, it is effective for the treatment of fibromyalgia. It is widely used for a variety of neurological disorders and pain management.
This medication should be taken orally, twice daily, regardless of food. 1. Neuropathic Pain - Peripheral neuropathic pain: Initiate with a dose of 150 mg once daily; it can be increased to 300 mg once daily after 3 to 7 days, and if necessary, increased to a maximum of 600 mg in 7-day intervals. - Central neuropathic pain: Initiate with a dose of 150 mg once daily; increase to 300 mg once daily after one week, and then reach a target dosage of 600 mg one week later.
Administration is not recommended for children under 12 years of age and adolescents aged 12 to 17 due to insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behavior, so if mood changes or unusual behavior occur during treatment, consult a healthcare provider immediately. Do not use if you are allergic to any of the components of this medication or have certain genetic disorders. Diabetic patients should be cautious as weight gain may necessitate adjustments to blood glucose control medications. If symptoms of hypersensitivity such as swelling of the face or around the mouth occur, discontinue use immediately. Elderly patients may be at increased risk of falls due to dizziness or drowsiness, so caution is required. Visual disturbances or changes in eyesight may occur, so inform a healthcare professional if these symptoms emerge. Discontinuing this medication suddenly may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually under a healthcare provider's guidance. Patients with a history of substance abuse may have an increased risk of dependence on this medication; consultation with a healthcare provider before use is necessary. Patients with decreased kidney function may require dosage adjustments. Patients with severe heart disease need to be cautious while taking this medication. Taking this medication with opioid pain relievers may increase the central nervous system depressant effects, so caution is advised. In the early stages of pregnancy, there is a risk of fetal malformation, so women who are pregnant or planning to become pregnant must consult before use. Breastfeeding women should consider that this medication may pass into breast milk and may need to stop breastfeeding or this medication. Avoid driving or operating dangerous machinery until dizziness and drowsiness have resolved completely. In case of overdose, confusion, drowsiness, seizures, etc. may manifest, so immediate emergency treatment is required. Keep out of reach of children and avoid transferring to other containers.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, breathlessness or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headaches, thunderclap headaches, seizures, altered consciousness, vision changes, paralysis.
Dizziness, drowsiness, confusion, disorientation, irritability, depression, elation, decreased libido, insomnia, depersonalization, hypersensitivity, restlessness, anxiety, mood swings, emotional blunting, emotional elevation, difficulty finding appropriate terminology, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, apathy, ataxia, motor coordination abnormalities, balance disorders, memory loss, attention deficit, memory impairment, tremors, dysarthria, sensory abnormalities, sensory loss.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is advisable to keep the medicine at room temperature between 15 to 30 degrees Celsius, away from very hot or very cold locations.
A hard capsule with a reddish-brown upper part and a white lower part containing a white powder that is white or light yellow in color.
30 capsules/bottle, 60 capsules/bottle, 100 capsules/bottle (for export), 30 capsules/PTP (for export), 100 capsules/PTP (for export)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Youyoung Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.